JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB224144

Anti-cGAS antibody

5

(2 Reviews)

|

(17 Publications)

Rabbit Polyclonal CGAS antibody. Suitable for WB and reacts with Human samples. Cited in 17 publications. Immunogen corresponding to Recombinant Fragment Protein within Human CGAS aa 300 to C-terminus.

View Alternative Names

C6orf150, MB21D1, CGAS, Cyclic GMP-AMP synthase, cGAMP synthase, cGAS, h-cGAS, 2'3'-cGAMP synthase, Mab-21 domain-containing protein 1

1 Images
Western blot - Anti-cGAS antibody (AB224144)
  • WB

Supplier Data

Western blot - Anti-cGAS antibody (AB224144)

All lanes:

Western blot - Anti-cGAS antibody (ab224144)

Lane 1:

CACO-2 cell lysate

Lane 2:

HEK293 cell lysate

Predicted band size: 59 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

Recombinant Fragment Protein within Human CGAS aa 300 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

Q8N884

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "0.04-0.4 µg/mL", "WB-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.2 Preservative: 0.02% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine)
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The cyclic GMP-AMP synthase commonly referred to as cGAS functions as an enzyme that detects cytosolic DNA. It has a molecular weight of 50 kDa. This protein is widely expressed in various cell types with high expression in cells exposed to foreign DNA such as immune cells. cGAS acts by binding to cytosolic DNA which leads to the production of the secondary messenger cyclic GMP-AMP (cGAMP). This action is critical for initiating innate immune responses against viral infections and cellular stress.
Biological function summary

CGAS plays a fundamental role in the immune response by activating the STING pathway. cGAS when bound to DNA forms a complex with DNA as part of its mechanistic function which then catalyzes the synthesis of cGAMP. The cGAMP produced acts as a signaling molecule that activates the STING protein leading to subsequent immune signaling cascades. This activation results in the production of type I interferons and other inflammatory cytokines essential for mounting an effective antiviral response.

Pathways

CGAS operates within important signaling pathways such as the cGAS-STING pathway and the type I interferon pathway. This protein works closely with STING located on the endoplasmic reticulum as a direct effector. The connection between cGAS and STING is important in detecting and responding to cytosolic DNA and initiating immune signaling leading to activation of downstream transcription factors like IRF3 and NF-kB which promote gene expression driving immune responses.

CGAS links to autoimmune diseases and cancer. Aberrant cGAS activity can lead to inappropriate immune activation contributing to autoimmune disorders such as lupus where the body attacks its own cells. In the case of cancer cGAS can play dual roles either promoting an immune response against tumors or contributing to an environment where cancer can evade immune detection. The relation between cGAS and diseases also involves STING as disruptions in this pathway can lead to alterations in immune surveillance and inflammation.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Nucleotidyltransferase that catalyzes the formation of cyclic GMP-AMP (2',3'-cGAMP) from ATP and GTP and plays a key role in innate immunity (PubMed : 21478870, PubMed : 23258413, PubMed : 23707061, PubMed : 23707065, PubMed : 23722159, PubMed : 24077100, PubMed : 24116191, PubMed : 24462292, PubMed : 25131990, PubMed : 26300263, PubMed : 29976794, PubMed : 30799039, PubMed : 31142647, PubMed : 32814054, PubMed : 33273464, PubMed : 33542149, PubMed : 37217469, PubMed : 37802025). Catalysis involves both the formation of a 2',5' phosphodiester linkage at the GpA step and the formation of a 3',5' phosphodiester linkage at the ApG step, producing c[G(2',5')pA(3',5')p] (PubMed : 28214358, PubMed : 28363908). Acts as a key DNA sensor : directly binds double-stranded DNA (dsDNA), inducing the formation of liquid-like droplets in which CGAS is activated, leading to synthesis of 2',3'-cGAMP, a second messenger that binds to and activates STING1, thereby triggering type-I interferon production (PubMed : 28314590, PubMed : 28363908, PubMed : 29976794, PubMed : 32817552, PubMed : 33230297, PubMed : 33606975, PubMed : 35322803, PubMed : 35438208, PubMed : 35460603, PubMed : 35503863). Preferentially recognizes and binds curved long dsDNAs of a minimal length of 40 bp (PubMed : 30007416). Acts as a key foreign DNA sensor, the presence of double-stranded DNA (dsDNA) in the cytoplasm being a danger signal that triggers the immune responses (PubMed : 28363908). Has antiviral activity by sensing the presence of dsDNA from DNA viruses in the cytoplasm (PubMed : 28363908, PubMed : 35613581). Also acts as an innate immune sensor of infection by retroviruses, such as HIV-2, by detecting the presence of reverse-transcribed DNA in the cytosol (PubMed : 23929945, PubMed : 24269171, PubMed : 30270045, PubMed : 32852081). In contrast, HIV-1 is poorly sensed by CGAS, due to its capsid that cloaks viral DNA from CGAS detection (PubMed : 24269171, PubMed : 30270045, PubMed : 32852081). Detection of retroviral reverse-transcribed DNA in the cytosol may be indirect and be mediated via interaction with PQBP1, which directly binds reverse-transcribed retroviral DNA (PubMed : 26046437). Also detects the presence of DNA from bacteria, such as M.tuberculosis (PubMed : 26048138). 2',3'-cGAMP can be transferred from producing cells to neighboring cells through gap junctions, leading to promote STING1 activation and convey immune response to connecting cells (PubMed : 24077100, PubMed : 31992625). 2',3'-cGAMP can also be transferred between cells by virtue of packaging within viral particles contributing to IFN-induction in newly infected cells in a cGAS-independent but STING1-dependent manner (PubMed : 26229115). Also senses the presence of neutrophil extracellular traps (NETs) that are translocated to the cytosol following phagocytosis, leading to synthesis of 2',3'-cGAMP (PubMed : 33688080). In addition to foreign DNA, can also be activated by endogenous nuclear or mitochondrial DNA (PubMed : 28738408, PubMed : 28759889, PubMed : 31299200, PubMed : 33031745, PubMed : 33230297). When self-DNA leaks into the cytosol during cellular stress (such as mitochondrial stress, SARS-CoV-2 infection causing severe COVID-19 disease, DNA damage, mitotic arrest or senescence), or is present in form of cytosolic micronuclei, CGAS is activated leading to a state of sterile inflammation (PubMed : 28738408, PubMed : 28759889, PubMed : 31299200, PubMed : 33031745, PubMed : 33230297, PubMed : 35045565). Acts as a regulator of cellular senescence by binding to cytosolic chromatin fragments that are present in senescent cells, leading to trigger type-I interferon production via STING1 and promote cellular senescence (By similarity). Also involved in the inflammatory response to genome instability and double-stranded DNA breaks : acts by localizing to micronuclei arising from genome instability (PubMed : 28738408, PubMed : 28759889). Micronuclei, which are frequently found in cancer cells, consist of chromatin surrounded by their own nuclear membrane : following breakdown of the micronuclear envelope, a process associated with chromothripsis, CGAS binds self-DNA exposed to the cytosol, leading to 2',3'-cGAMP synthesis and subsequent activation of STING1 and type-I interferon production (PubMed : 28738408, PubMed : 28759889). Activated in response to prolonged mitotic arrest, promoting mitotic cell death (PubMed : 31299200). In a healthy cell, CGAS is however kept inactive even in cellular events that directly expose it to self-DNA, such as mitosis, when cGAS associates with chromatin directly after nuclear envelope breakdown or remains in the form of postmitotic persistent nuclear cGAS pools bound to chromatin (PubMed : 31299200, PubMed : 33542149). Nuclear CGAS is inactivated by chromatin via direct interaction with nucleosomes, which block CGAS from DNA binding and thus prevent CGAS-induced autoimmunity (PubMed : 31299200, PubMed : 32911482, PubMed : 32912999, PubMed : 33051594, PubMed : 33542149). Also acts as a suppressor of DNA repair in response to DNA damage : inhibits homologous recombination repair by interacting with PARP1, the CGAS-PARP1 interaction leading to impede the formation of the PARP1-TIMELESS complex (PubMed : 30356214, PubMed : 31544964). In addition to DNA, also sense translation stress : in response to translation stress, translocates to the cytosol and associates with collided ribosomes, promoting its activation and triggering type-I interferon production (PubMed : 34111399). In contrast to other mammals, human CGAS displays species-specific mechanisms of DNA recognition and produces less 2',3'-cGAMP, allowing a more fine-tuned response to pathogens (PubMed : 30007416).
See full target information CGAS

Publications (17)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in immunology 16:1592737 PubMed40799648

2025

RORα-activated mitophagy attenuating hypoxic-ischemic encephalopathy via suppression of microglial cGAS-STING axis.

Applications

Unspecified application

Species

Unspecified reactive species

Lei Song,Haiyan Shen,Fei Hong,Weiyan Zhang,Hongyi Lu

The EMBO journal 43:3587-3603 PubMed38951609

2024

LINE-1 RNA triggers matrix formation in bone cells via a PKR-mediated inflammatory response.

Applications

Unspecified application

Species

Unspecified reactive species

Arianna Mangiavacchi,Gabriele Morelli,Sjur Reppe,Alfonso Saera-Vila,Peng Liu,Benjamin Eggerschwiler,Huoming Zhang,Dalila Bensaddek,Elisa A Casanova,Carolina Medina Gomez,Vid Prijatelj,Francesco Della Valle,Nazerke Atinbayeva,Juan Carlos Izpisua Belmonte,Fernando Rivadeneira,Paolo Cinelli,Kaare Morten Gautvik,Valerio Orlando

Journal for immunotherapy of cancer 12: PubMed38749537

2024

Colorectal cancer-specific IFNβ delivery overcomes dysfunctional dsRNA-mediated type I interferon signaling to increase the abscopal effect of radiotherapy.

Applications

Unspecified application

Species

Unspecified reactive species

Kevin Chih-Yang Huang,Shu-Fen Chiang,Hsin-Yu Chang,Wei-Ze Hong,Jhen-Yu Chen,Pei-Chih Lee,Ji-An Liang,Tao-Wei Ke,Shin-Lei Peng,An-Cheng Shiau,Tsung-Wei Chen,Pei-Chen Yang,William Tzu-Liang Chen,K S Clifford Chao

Cancer immunology, immunotherapy : CII 73:92 PubMed38564022

2024

Activation of STING by the novel liposomal TLC388 enhances the therapeutic response to anti-PD-1 antibodies in combination with radiotherapy.

Applications

Unspecified application

Species

Unspecified reactive species

Jhen-Yu Chen,Po-Yu Lin,Wei-Ze Hong,Pei-Chen Yang,Shu-Fen Chiang,Hsin-Yu Chang,Tao-Wei Ke,Ji-An Liang,William Tzu-Liang Chen,K S Clifford Chao,Kevin Chih-Yang Huang

British journal of cancer 129:1852-1862 PubMed37838813

2023

Preoperative chemoradiotherapy induces multiple pathways related to anti-tumour immunity in rectal cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Ioannis M Koukourakis,Erasmia Xanthopoulou,Theologos I Sgouras,Maria Kouroupi,Alexandra Giatromanolaki,Vassilios Kouloulias,Dina Tiniakos,Anna Zygogianni

Bioactive materials 30:200-213 PubMed37663305

2023

Combination of bacterial-targeted delivery of gold-based AIEgen radiosensitizer for fluorescence-image-guided enhanced radio-immunotherapy against advanced cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Yanhong Duo,Zide Chen,Zihuang Li,Xing Li,Yaoqiang Yao,Tianzhao Xu,Ge Gao,Guanghong Luo

International journal of radiation oncology, biology, physics 117:955-965 PubMed37244631

2023

Activation of STING in Response to Partial-Tumor Radiation Exposure.

Applications

Unspecified application

Species

Unspecified reactive species

Mickael Mathieu,Sadna Budhu,Prerna R Nepali,James Russell,Simon N Powell,John Humm,Joseph O Deasy,Adriana Haimovitz-Friedman

Cell death discovery 9:136 PubMed37100799

2023

High glucose-induced STING activation inhibits diabetic wound healing through promoting M1 polarization of macrophages.

Applications

Unspecified application

Species

Unspecified reactive species

Kang Geng,Xiumei Ma,Zongzhe Jiang,Wei Huang,Junling Gu,Peng Wang,Lifang Luo,Youhua Xu,Yong Xu

The EMBO journal 42:e111961 PubMed36574362

2022

DNA damage repair kinase DNA-PK and cGAS synergize to induce cancer-related inflammation in glioblastoma.

Applications

Unspecified application

Species

Unspecified reactive species

Clara Taffoni,Johanna Marines,Hanane Chamma,Soumyabrata Guha,Mathilde Saccas,Amel Bouzid,Ana-Luiza Chaves Valadao,Clément Maghe,Jane Jardine,Mi Kyung Park,Katarzyna Polak,Mara De Martino,Claire Vanpouille-Box,Maguy Del Rio,Celine Gongora,Julie Gavard,Nicolas Bidère,Min Sup Song,Donovan Pineau,Jean-Philippe Hugnot,Karima Kissa,Laura Fontenille,Fabien P Blanchet,Isabelle K Vila,Nadine Laguette

Vaccines 10: PubMed36560581

2022

Ag85a-S2 Activates cGAS-STING Signaling Pathway in Intestinal Mucosal Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Sheng Dang,Wanyang Li,Shubo Wen,Yang Song,Meirong Bai,Shuyan Li,Zeliang Chen,Jingbo Zhai
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com